title: [Pathological jealousy].
abstract: Pathological jealousy can make life unbearable for all concerned. The proximity of this condition to obsessive-compulsive phenomena has given rise to the notion that it might respond to substances of proven value in the treatment of obsessive-compulsive disorders. This case history exemplifies the successful treatment of pathological jealousy with the selective serotonin reuptake inhibitor (SSRI) fluoxetine. The substance not only proved to be a successful antidepressant, but also effectively mitigated the anguish of the patient's pathological jealousy. On the basis of these findings, fluoxetine--as also other SSRIs--should always be considered as a possible effective pharmacological strategy for the treatment of pathological jealousy.
authors.forename: A
authors.initials: A
authors.lastname: Zacher
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation; D003193:Compulsive Personality Disorder / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D007578:Jealousy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
chemical_list: D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors